EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib

David Sanford, Maria MacDonald, Michael Nicolle, Anargyros Xenocostas

Hematology Reports · 2014

DOI: 10.4081/hr.2014.5288 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hematology Reports, 2014. Verfasst von David Sanford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology, University of Western Ontario , London, ON, Canada. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adverse drug eventschronic myeloid leukemiatyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology, University of Western Ontario , London, ON, Canada.
  • Department of Oncology, University of Western Ontario , London, ON, Canada.
  • Department of Oncology, University of Western Ontario , London, ON, Canada ; Department of Clinical Neurological Sciences, University of Western Ontario , London, ON, Canada.

Zitieren

APA

Sanford, D., MacDonald, M., Nicolle, M., & Xenocostas, A. (2014). Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib. Hematology Reports. https://doi.org/10.4081/hr.2014.5288

Vancouver

Sanford D, MacDonald M, Nicolle M, Xenocostas A. Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib. Hematology Reports. 2014. doi:10.4081/hr.2014.5288

BibTeX
@article{Sanford2014,
  author = {Sanford, David and MacDonald, Maria and Nicolle, Michael and Xenocostas, Anargyros},
  title = {Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib},
  journal = {Hematology Reports},
  year = {2014},
  doi = {10.4081/hr.2014.5288}
}
Kostenlos starten →